Table 2.
Baseline characteristics of ACS patients in accordance of the presence of known DM
| Variable | All pts | DM pts | NDM pts | Sig (p) | |
|---|---|---|---|---|---|
| Risk factors | |||||
| HTA | 85 (56 .7%) | 32 (65 .3%) | 53 (52 .5) | ns (OR for HTA in DM pts 1 .7; CI 0 .84-3 .45; p=ns) | |
| HLP | 22 (14 .7%) | 7 (14 .3%) | 15 (14 .8%) | ns | |
| Family history | 48 (32%) | 17 (34 .7%) | 31 (30 .7%) | ns | |
| smoking | 89 (59 .3%) | 20 (40 .8%) | 69 (68 .3%) | 0 .001 (OR for NDM smokers is 2 .1; CI 1 .16-2 .4; p=0 .002) | |
| LV function | |||||
| EF (%) | 51 .3±8 .1 | 51 .0±7 .3 | 51 .4±8 .5 | 0 .802 (ns) | |
| LV systolic function | |||||
| Normal (EF >50%) | 83 (55 .3%) | 25 (51 .0%) | 58 (57 .4%) | 0 .247(ns) | |
| Reduced (EF <50%) | 59 (39 .3%) | 23 (46 .9%) | 36 (35 .6%) | ||
| Severely reduced (<30%) | 8 (5 .3%) | 1 (2 .1%) | 7 (7%) | ||
| LV diastolic dysfunction | 65 (43 .3%) | 21 (42 .8%) | 44 (43 .6%) | 0 .538 (ns) | |
| CA | 132 (88%) | 45 (91 .8%) | 87 (86 .1%) | 0 .184 (ns) 0 .365(ns) | |
| SINTAX score | 15 .6±8 .1 | 16 .5±8 .5 | 15 .1±7 .9 | ||
| TIMI score before treatment | |||||
| 0 | 63 (47 .7%) | 23 (55 .5%) | 40 (45 .9%) | ||
| 1 | 7 (5 .3%) | 2 (4 .4%) | 5 (5 .7%) | 0 .862 (ns) | |
| 2 | 7 (5 .3%) | 3 (6 .7%) | 4 (4 .6%) | ||
| 3 | 55 (41 .7%) | 17 (37 .8%) | 38 (43 .7%) | ||
| TIMI score after treatment | |||||
| 0 | 8 (6 .1%) | 5 (11 .1%) | 3 (3 .4%) | 0 .162 (ns) | |
| 1 | |||||
| 2 | 4 (3 .0%) | 2 (4 .4%) | 2 (2 .3%) | ||
| 3 | 120 (90 .9%) | 38 (84 .4%) | 82 (94 .4%) | ||
| Blood analyses | |||||
| Hgb | 14 .1±1.8 | 14 .0±1.6 | 14 .1±1.9 | 0 .678 (ns) | |
| BUN | 7 .1±4 .5 | 7 .5±4 .6 | 6 .9±4 .5 | 0 .455 (ns) | |
| Creatinine | 95 .7±72 .6 | 105 .3±106 .7 | 91 .0±48 .2 | 0 .260 (ns) | |
| Na | 137 .5±4 .5 | 135 .2±5 .4 | 138 .5±3 .6 | 0 .000 | |
| K | 4 .3±0 .7 | 4 .4±0 .7 | 4 .2±0 .6 | 0 .103 (ns) | |
| Lipid profile | |||||
| Tg | 1 .8±0.8 | 1 .9±0.9 | 1 .7±0.8 | 0 .041 | |
| HDL chol | 1 .2±0 .4 | 1 .1±0 .2 | 1 .2±0 .4 | 0 .483 (ns) | |
| LDL chol | 3 .3±1 .2 | 3 .4±1 .1 | 3 .3±1 .2 | 0 .615 (ns) | |
| Lp(a) | 35 .0±33 .2 | 38 .8±35 .3 | 33 .2±32 .3 | 0 .334 (ns) | |
| Glycemic parameters | |||||
| Stress glycaemia | 10 .3±6 .6 | 14 .8±7 .9 | 8 .2±4 .5 | 0 .000 | |
| HgbA1C | 6 .4±1 .5 | 8 .2±4 .5 | 5 .7±0 .8 | 0 .000 | |
| In-hospital CE | 31 (20 .7%) | 11 (22 .4%) | 20 (19 .8%) | 0 .431 (ns) | |
| Cardiac death (5) | 11 (7 .3%) | 5 (10 .2%) | 6 (5 .9) | 0 .266 (ns) | |
| Length of hospitalization | 4 .5±3 .0 | 4 .4±2 .8 | 4 .5±3 .1 | 0 .881 (ns) | |